Xponance Inc. Purchases 718 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Xponance Inc. increased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 6.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 12,276 shares of the company’s stock after purchasing an additional 718 shares during the quarter. Xponance Inc.’s holdings in HealthEquity were worth $1,178,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of HQY. Intech Investment Management LLC increased its stake in HealthEquity by 59.5% in the 3rd quarter. Intech Investment Management LLC now owns 21,064 shares of the company’s stock worth $1,724,000 after buying an additional 7,859 shares during the period. Massachusetts Financial Services Co. MA grew its stake in HealthEquity by 7.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 484,782 shares of the company’s stock worth $39,679,000 after acquiring an additional 33,523 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of HealthEquity by 1.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,061,807 shares of the company’s stock worth $86,909,000 after acquiring an additional 14,532 shares during the period. Raymond James Trust N.A. raised its stake in shares of HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after acquiring an additional 132 shares in the last quarter. Finally, Citigroup Inc. boosted its holdings in shares of HealthEquity by 73.0% in the third quarter. Citigroup Inc. now owns 102,107 shares of the company’s stock valued at $8,357,000 after purchasing an additional 43,084 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 2.20% of the stock is owned by insiders.

Analyst Ratings Changes

HQY has been the topic of several research reports. Wells Fargo & Company raised their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Raymond James raised their price target on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Mizuho assumed coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. Finally, Barrington Research restated an “outperform” rating and issued a $112.00 price target on shares of HealthEquity in a report on Friday, March 14th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $112.92.

HealthEquity Stock Up 0.3 %

Shares of HealthEquity stock opened at $84.88 on Monday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market cap of $7.36 billion, a P/E ratio of 77.87, a PEG ratio of 1.60 and a beta of 0.62. The firm’s 50 day moving average price is $104.90 and its 200-day moving average price is $95.76. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.